Placeholder Banner

Select Committee on Climate Crisis: BIO Comments on Public Policies Needed to Help Biotech Address Climate Change

December 20, 2019

The Biotechnology Innovation Organization (BIO) is pleased to respond to the Select Committee's Request for Information (RFI) on how supportive public policy can help biotechnology reduce greenhouse gas emissions, enhance carbon sequestration, mitigate the effects of climate change, enhance public response to public health emergencies, and speed the transition of the U.S. economy to one that is more bio-based—benefiting the environment, public health, and our national economy. 

Download Full Comments Below
BIO Comments on Public Policy Needed to Enable Biotech to Address Climate Crisis
Discover More
February 14, 2020 Re: Docket No. FDA–2020-D-0529: FDA Draft Guidance, Qualification Process for Drug Development Tools Dear Sir/Madam:  The Biotechnology Innovation Organization (BIO) thanks the Food and Drug Administration (FDA or Agency)…
Dear Administrator McCarthy, We write to request that the Environmental Protection Agency (EPA) update its greenhouse gas life-cycle emissions analysis for corn ethanol to include consideration of the current state of the industry and the published…
February 11, 2020 Re: Docket No. FDA–2019-D-4751: Food and Drug Administration Reauthorization Act Implementation Guidance for Pediatric Studies of Molecularly Targeted Oncology Drugs Dear Sir/Madam: The Biotechnology Innovation Organization (BIO…